Publications - 'P'

Publications 1476 - 1500 de 2458
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
Predictive and Evolutive Cross-Referencing for Web Textual Sources
T. Hassan; C. Cruz; A. Bertaux
2017
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study
R.J. Young; S. Litiere; M. Lia; P.C.W. Hogendoorn; C. Fisher; G. Mechtersheimer; S. Daugaard; R. Sciot; F. Collin; C. Messiou; V. Gruenwald; A. Gronchi; W. van der Graaf; E. Wardelmann; I. Judson
2017
10.1080/0284186X.2017.1315173
Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa
A. d'Elia; D. Evans; L. McNamara; R. Berhanu; I. Sanne; E. Lonnermark
2015
10.11604/pamj.2015.22.4.6075
Predictive and prognostic value of circulating tumor DNA (ctDNA) compared to circulating tumor cells (CTC) in a prospective cohort of metastatic breast cancer patients: The UCBG COMET trial
J.Y. Pierga; A. Silveira; E. Girard; V. Lorgis; M.L. Tanguy; B. Albaud; O. Tredan; C. Dubot; C. Hego; W. Jacot; A. Goncalves; M. Debled; C. Levy; J.M. Ferrero; C. Jouannaud; M.A. Mouret-Reynier; F. Dalenc; S. Baulande; J. Lemonnier; F. Berger; F.C. Bidard; C. Proudhon
2020
10.1158/1538-7445.AM2020-3390
Predictive Control Based on Nonlinear Observer for Muscular Force and Fatigue Model
T. Bakir; B. Bonnard; S. Othman
2018
Predictive Control Based on Nonlinear Observer for Muscular Force and Fatigue Model
T. Bakir; B. Bonnard; S. Othman
2018
Predictive Energy Management for Hybrid Vehicles based on Driving Cycle Recognition
L. Joud; D. Chrenko; A. Keromnes; R. Da Silva; L. Le Moyne
2017
Predictive factors for early progression during induction chemotherapy (IC) and chemotherapy-free interval (CFI): Analysis from PRODIGE 9 trial
T. Aparicio; J. Bennouna; K. Le Malicot; V. Boige; J. Taieb; O. Bouche; E. Francois; J.M. Phelip; C. Borel; R. Faroux; L. Dahan; J.B. Bachet; J. Egreteau; C. Kaminsky-Forrett; J.M. Gornet; O. Cojocarasu; M. Gasmi; V. Guerin-Meyer; F. Ghiringhelli; C. Lepage
2017
Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial
T. Aparicio; J. Bennouna; K. Le Malicot; V. Boige; J. Taieb; O. Bouche; J.M. Phelip; E. Francois; C. Borel; R. Faroux; L. Dahan; J.B. Bachet; J. Egreteau; M.C. Kaminsky; J.M. Gornet; O. Cojocarasu; M. Gasmi; V. Guerin-Meyer; C. Lepage; F. Ghiringhelli; P.R.O.D.I.G.E.Investigat Collaborator
2020
10.1038/s41416-020-0735-8
Predictive factors for exudation of quiescent choroidal neovessels detected by OCT angiography in the fellow eyes of eyes treated for a neovascular age-related macular degeneration
L. Solecki; P. Loganadane; A.S. Gauthier; M. Simonin; M. Puyraveau; B. Delbosc; M. Saleh
2021
10.1038/s41433-020-0936-7
Predictive factors for prolonged response to olaparib as maintenance therapy in ovarian cancer patients with BRCA mutations.
S.Intidhar Labidi-Galy; T.De la Mott Rouge; O. Derbel; E. Kalbacher; A. Wolfer; T. Olivier; K. Hu; O. Tredan; H. Guevara; F. Bazan; V. de Castelbajac; J.D. Combes; P. Vaflard; L. Crivelli; V. Bonadona; V. Viassolo; L. Golmard; A. Buisson; M. Rodrigues; I.Laure Ray-Coquard
2018
10.1200/JCO.2018.36.15_suppl.5558
Predictive factors of adherence to an association of glucosamine sulfate, copper, and ginger extracts in patients with symptomatic osteoarthritis: a prospective open-label French noninterventional study (the PREDOA study)
T. Conrozier; J.L. Renevier; J.M. Parisaux; J.C. Balblanc
2019
10.2147/PPA.S200892
Predictive factors of allergy to pistachio in children allergic to cashew nut
L. Saba; I. Clerc-Urmes; C. Delahaye; E. Chevillot; S. Jarlot-Chevaux; P. Dumond; C. Schweitzer; A. Divaret-Chauveau
2020
10.1111/pai.13238, Early Access Date = {MAR 2020
Predictive factors of allergy to pistachio in children allergic to cashew nut
L. Saba; I. Clerc-Urmes; C. Delahaye; E. Chevillot; S. Jarlot-Chevaux; P. Dumond; C. Schweitzer; A. Divaret-Chauveau
2020
10.1111/pai.13238
Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation
C. Aubron; J. DePuydt; F. Belon; M. Bailey; M. Schmidt; J. Sheldrake; D. Murphy; C. Scheinkestel; J. Cooper; G. Capellier; V. Pellegrino; D. Pilcher; Z. McQuilten
2016
10.1186/s13613-016-0196-7
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
L. Vercellino; R. Di Blasi; S. Kanoun; B. Tessoulin; C. Rossi; M. D'Aveni-Piney; L. Oberic; C. Bodet-Milin; P. Bories; P. Olivier; I. Lafon; A. Berriolo-Riedinger; E. Galli; S. Bernard; M.T. Rubio; C. Bossard; V. Meignin; P. Merlet; P. Feugier; S. Le Gouill; L. Ysebaert; O. Casasnovas; M. Meignan; S. Chevret; C. Thieblemont
2020
10.1182/bloodadvances.2020003001
PREDICTIVE FACTORS OF FAILURE OF VISCOSUPPLEMENTATION IN PATIENTS WITH KNEE OSTEOARTHRITIS. RESULTS OF A POST-HOC ANALYSIS OF A DOUBLE BLIND, CONTROLLED NON INFERIORITY TRIAL
F. Eymard; T. Conrozier; X. Chevalier
2016
10.1136/annrheumdis-2016-eular.3415
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)
A. Lohse; T. Klopfenstein; J.C. Balblanc; P.Y. Royer; M. Bossert; V. Gendrin; A. Charpentier; A.M. Bozgan; J. Badie; C. Bourgoin; R. Contreras; I. Mazurier; T. Conrozier; S. Zayet
2020
10.1016/j.micinf.2020.06.005
Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: Development of a specific predictor
C. Jankowski; S. Gulu; M. Cortet; D. Hudry; L. Arnould; C. Charon-Barra; I. Desmoulins; R. Rouzier; P. Fumoleau; B. Coudert; F. Reyal; C. Coutant
2016
10.1158/1538-7445.SABCS15-P1-14-21
Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis
C. Jankowski; S. Guiu; M. Cortet; C. Charon-Barra; I. Desmoulins; V. Lorgis; L. Arnould; P. Fumoleau; B. Coudert; R. Rouzier; C. Coutant; F. Reyal
2017
10.1007/s10549-016-4040-4
Predictive factors of poor outcomes in the COVID-19 epidemic: Consider the inflammatory response
J. Razanamahery; L. Malinowski; S. Humbert; A.S. Brunel; Q. Lepiller; C. Chirouze; K. Bouiller
2020
Predictive factors of poor outcomes in the COVID-19 epidemic: Consider the inflammatory response
J. Razanamahery; L. Malinowski; S. Humbert; A.S. Brunel; Q. Lepiller; C. Chirouze; K. Bouiller
2020
PREDICTIVE FACTORS OF RESPONSE TO A SINGLE INJECTION OF MANNITOL-MODIFIED CROSS-LINKED HYALURONIC ACID (HANOX-M-XL) IN PATIENTS WITH TRAPEZIOMETACARPAL OSTEOARTHRITIS. RESULTS OF A MULTICENTRE PROSPECTIVE OPEN-LABEL PILOT STUDY (INSTINCT TRIAL)
J. Dauvissat; T. Conrozier; H. Lellouche; B. Maillet; C. Rizzo; V. Travers; V. Locquet; S. Mellac-Ducamp
2018
10.1136/annrheumdis-2018-eular.3317
Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Federation Francophone de Cancerologie Digestive (FFCD) trials
C. Breton; T. Aparicio; K. Le Malicot; M. Ducreux; T. Lecomte; J.B. Bachet; J. Taieb; J.L. Legoux; A. de Gramont; J. Bennouna; O. Bouche; O. Boussari; S. Manfredi; J.M. Gornet
2021
10.1016/j.ejca.2021.04.040
Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group
A. Lafarge; A. Joseph; C. Pagnoux; X. Puechal; P. Cohen; M. Samson; M. Hamidou; A. Karras; T. Quemeneur; C. Ribi; M. Groh; L. Mouthon; L. Guillevin; B. Terrier; F.Vasculitis FVSG
2020
10.1093/rheumatology/kez575

Pages